NEWS & EVENTS 
SPECIALTY CARE
Medications and CGM Coverage Guide
Updated: 01/21/26
Quickly reference insurance plan coverage in this all-in-one guide for your patients with type 2 diabetes.
Medications and devices referenced include:
SGLT2 Inhibitors
Farxiga, Jardiance, Invokana, Steglatro, dapagliflozin
GLP-1 Receptor Agonists / GIPs
Mounjaro, Ozempic, Rybelsus, Trulicity, Victoza, liraglutide
Anti-Obesity Medications
Contrave, Lomaira, phentermine, Qsymia, Saxenda, Wegovy, Zepbound
Continuous Glucose Monitors (CGMs)
Device brands preferred by each payor
Plans include major commercial plans/PBMs in Michigan (Aetna, BCBSM, Express Scripts, HAP, Priority Traditional, Priority Optimized, and United), as well as Medicare, Medicare Advantage plans (Aetna, BCBSM/BCN, HAP, Humana, Priority, United, and Wellcare), and Michigan Medicaid.
Developed by the Michigan Collaborative for Type 2 Diabetes.
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.